LANDINI, IDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.599
EU - Europa 4.718
AS - Asia 2.948
SA - Sud America 268
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 81
OC - Oceania 42
Totale 14.801
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.475
PL - Polonia 1.373
RU - Federazione Russa 1.360
SG - Singapore 885
CN - Cina 766
IT - Italia 755
HK - Hong Kong 397
IE - Irlanda 294
VN - Vietnam 256
SE - Svezia 242
KR - Corea 228
BR - Brasile 218
FI - Finlandia 181
DE - Germania 151
FR - Francia 118
IN - India 110
GB - Regno Unito 89
CA - Canada 76
JO - Giordania 66
JP - Giappone 57
BD - Bangladesh 42
AU - Australia 40
TR - Turchia 30
CH - Svizzera 29
ES - Italia 23
AT - Austria 21
ID - Indonesia 21
MX - Messico 21
UA - Ucraina 21
AR - Argentina 19
IQ - Iraq 18
NL - Olanda 18
ZA - Sudafrica 16
BE - Belgio 14
CI - Costa d'Avorio 14
PK - Pakistan 13
NG - Nigeria 12
EC - Ecuador 8
MA - Marocco 8
PH - Filippine 8
SA - Arabia Saudita 8
EG - Egitto 7
CO - Colombia 6
DZ - Algeria 6
VE - Venezuela 6
BJ - Benin 5
UZ - Uzbekistan 5
GR - Grecia 4
IL - Israele 4
LT - Lituania 4
OM - Oman 4
TW - Taiwan 4
CL - Cile 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
PE - Perù 3
TH - Thailandia 3
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LB - Libano 2
MQ - Martinica 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
PY - Paraguay 2
QA - Qatar 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BM - Bermuda 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GI - Gibilterra 1
GN - Guinea 1
GY - Guiana 1
HR - Croazia 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
Totale 14.645
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.388
Warsaw 1.362
Ashburn 839
Singapore 618
Fairfield 445
Chandler 328
Hong Kong 328
Dublin 292
San Jose 274
Seattle 227
Seoul 224
Woodbridge 220
Houston 206
Cambridge 202
Beijing 175
Wilmington 163
Hefei 149
Ann Arbor 141
Florence 128
Milan 126
Council Bluffs 122
Helsinki 105
Buffalo 92
Altamura 85
Lawrence 78
Dallas 76
Los Angeles 75
The Dalles 75
Ho Chi Minh City 74
Princeton 69
Lauterbourg 64
New York 62
Hanoi 61
Chicago 60
Boston 52
Tokyo 52
Rome 47
Boardman 46
Mumbai 44
Moscow 43
Munich 43
Bremen 42
Shanghai 41
Melbourne 40
Kent 37
Jacksonville 36
Paris 33
Medford 31
Falls Church 27
Turku 26
San Diego 25
London 23
Bern 22
Chennai 22
Clifton 21
Toronto 21
Phoenix 19
Orem 18
Redondo Beach 18
Vienna 18
Da Nang 17
Jakarta 17
São Paulo 17
Guangzhou 16
Figino 15
Abidjan 14
Brussels 14
Johannesburg 13
Naples 13
Hillsboro 12
Palermo 12
Abuja 11
Barcelona 11
Izmir 11
Norwalk 11
Turin 11
Bengaluru 10
Brooklyn 10
Dong Ket 10
Haiphong 10
Montreal 10
Pune 10
Stockholm 10
Frankfurt am Main 9
Lappeenranta 9
Miano 9
Dearborn 8
Mexico City 8
Norwich 8
Venice 8
Bari 7
Bologna 7
Shenzhen 7
Surrey 7
Tianjin 7
Zurich 7
Amsterdam 6
Poplar 6
San Francisco 6
Wuhan 6
Totale 10.190
Salva come PNG Salva come JPEG
Nome #
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 373
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. 361
Proteomic Analysis of Ovarian Cancer Cell Responses to Cytotoxic Gold Compounds 357
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 355
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 344
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 342
Emerging drugs in refractory colorectal cancer 334
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 322
Druggable Targets in Pancreatic Adenocarcinoma 313
Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 308
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 282
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 266
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 255
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 254
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 244
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 242
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 241
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 234
Cellular pharmacology of gemcitabine. 231
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 228
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives. 220
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study. 216
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 214
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 206
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 205
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors. 199
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 198
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 197
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 193
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 192
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 189
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 185
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 182
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 181
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 179
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 176
Synthesis, Structural Characterization, Solution Behavior, and in Vitro Antiproliferative Properties of a Series of Gold Complexes with 2-(2'-Pyridyl)benzimidazole as Ligand: Comparisons of Gold(III) versus Gold(I) and Mononuclear versus Binuclear Derivatives 172
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 171
The clinical role of PIK3CA mutations in colorectal cancer 169
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 168
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy 168
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 164
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study 161
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 160
Pharmacological strategies for overcoming multidrug resistance. 160
Size dependent biological profiles of PEGylated gold nanorods 160
In vitro cell growth inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on human tumor cell lines with defective DNA damage response pathways 159
Molecular characterization of established human colorectal carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil (5-FU) by different selective schedules 159
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 153
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 152
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand. 149
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 149
Role of ATP-binding cassette transporters in cancer initiation and progression 148
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 147
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 147
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 146
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. 145
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 144
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 142
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 141
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 138
Effects of reduced extracellular sodium on proliferation and invasive activity of renal cell carcinoma cell lines 135
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 134
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 133
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 131
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 129
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 128
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 125
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 123
P118 A preliminary study for evaluation of cannabis - chemotherapy interactions on human colon cancer cells 117
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients 117
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 101
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 90
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 89
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 89
Sequence-dependent interactions between oxaliplatin (OHP) and 5-fluorouracil (5-FU) in human colon carcinoma cell lines 84
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1. 76
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 73
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 35
null 2
Totale 14.801
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.932
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022498 0 40 39 17 22 28 36 48 30 17 91 130
2022/20231.480 111 265 68 141 114 262 174 84 174 7 31 49
2023/2024617 21 55 79 16 32 67 82 157 15 21 43 29
2024/20253.818 135 361 242 591 1.092 573 48 176 198 97 144 161
2025/20264.566 532 552 391 335 542 192 597 218 292 332 139 444
2026/2027295 167 128 0 0 0 0 0 0 0 0 0 0
Totale 14.801